top of page

INDUSTRIES  /  CDMOS & CROS

Know which sponsors your competitors are working, and with how many people.

FUNCTIONS WE MAP

01    Business development

02    Account management

03    Scientific sales

Org maps of competitor business development, account management and scientific sales teams, for strategy and commercial leaders at contract development, manufacturing and research organizations.

Technician in cleanroom gear reviewing batch data on a tablet

Who uses it

Business development, commercial strategy, marketing and corporate strategy leaders at CDMOs, CROs and other outsourced service providers to pharmaceutical and biotech sponsors.

The decisions it informs

  • Which sponsor accounts to prioritize, and how competitors cover them

  • How to structure business development teams by modality, sponsor size or region

  • Where competitors are adding capacity and the commercial teams to fill it

  • Pricing and proposal strategy when you know who else is bidding and how they staff a program

  • Capability investments in modalities such as biologics, cell and gene therapy, ADCs or peptides

Why structure matters here

Outsourced services are sold through relationships between a provider's business development and scientific staff and a sponsor's outsourcing, CMC and clinical operations teams. How a competitor organizes those relationships, and where it is hiring, signals which sponsors and modalities it is chasing before an announcement or a capacity press release.

Questions we answer

  • Is a competitor's business development team organized by modality, sponsor tier or region?

  • How many account directors and scientific business development staff cover large pharma versus emerging biotech?

  • Which sponsors does a competitor treat as strategic accounts, and who owns them?

  • Where is a competitor adding sales and project management staff alongside new capacity?

START HERE

Every engagement starts with the question you need answered.

Tell us which competitors and which functions matter to the decision in front of you. We'll scope what can be mapped, how, and by when.

bottom of page